In this issue:
Automated insulin delivery in type 2 diabetes
SOUL: cardiovascular outcomes with oral semaglutide in high-risk type 2 diabetes
STRIDE: walking distance with semaglutide in type 2 diabetes with PAD
Efficacies of SGLT2is, GLP-1 RAs & DPP-4is by age/sex
Sleep & long-term type 2 diabetes risk in women with gestational diabetes
COPD exacerbations with SGLT-2is, GLP-1
RAs & DPP-4is in type 2 diabetes
Hybrid closed-loop therapy in type 1 diabetes patients aged 2–20 years
Maternal diabetes & neurodevelopmental outcomes in children
PAD-related surgical events with add-on SGLT2i vs. DPP-4i
Finerenone in type 2 diabetes
Please login below to download this issue (PDF)